Cigna-Express Scripts deal clears regulatory hurdles in California, New York

Cigna and Express Scripts gained approval from California and New York regulators to move forward with their $67 billion merger, according to filings with the Securities and Exchange Commission.

Advertisement

California and New York regulators both issued their approvals Dec. 13. Cigna and Express Scripts said New Jersey is the last state from which the companies need approval to continue with the transaction.

The health insurer and pharmacy benefits manager still expect their deal to close by the end of 2018, despite missing an original Dec. 8 deadline. The companies’ new merger termination date is June 8, 2019, according to a Nov. 21 Securities and Exchange Commission filing.

More articles on payers:
CMS’ final rule on risk adjustment payments: 3 things to know
BCBS of Wyoming customers overcharged due to banking error
ACA plan enrollment falls 11%: 3 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.